Dr. Shelley Chu joins Abingworth
Abingworth said Monday that Shelley Chu MD, PhD has joined Abingworth as a Partner. Chu was previously with Gilead Sciences where she led Business Development in Oncology, Immunotherapy and Hepatitis B, as well as R&D Strategy.
19 October 2015•2 mins read
